University of Grenoble Alpes, Inserm, U1216, Grenoble Institut Neurosciences, Grenoble, France.
EA University Paris Est Créteil, Health Faculty, Créteil, France; AP-HP, Clinical Neurophysiology Unit, Henri Mondor Hospital, Créteil, France.
Neuromodulation. 2024 Jan;27(1):188-199. doi: 10.1016/j.neurom.2023.05.005. Epub 2023 Aug 16.
Complex regional pain syndrome (CRPS) is a chronic pain condition involving autonomic dysregulation. In this study, we report the results of an ancillary study to a larger clinical trial investigating the treatment of CRPS by neuromodulation. This ancillary study, based on functional magnetic resonance imaging (fMRI), evaluated the neural correlates of pain in patients with CRPS in relation to the sympathetic nervous system and for its potential relief after repetitive transcranial magnetic stimulation of the motor cortex.
Eleven patients with CRPS at one limb (six women, five men, aged 52.0 ± 9.6 years) were assessed before and one month after the end of a five-month repetitive transcranial magnetic stimulation (rTMS) therapy targeting the motor cortex contralateral to the painful limb, by means of electrochemical skin conductance (ESC) measurement, daily pain intensity scores on a visual numerical scale (VNS), and fMRI with motor tasks (alternation of finger movements and rest). The fMRI scans were analyzed voxelwise using ESC and VNS pain score as regressors to derive their neural correlates. The criterion of response to rTMS therapy was defined as ≥30% reduction in VNS pain score one month after treatment compared with baseline.
At baseline, ESC values were reduced in the affected limb vs the nonaffected limb. There was a covariance of VNS with brain activation in a small region of the primary somatosensory cortex (S1) contralateral to the painful side on fMRI investigation. After rTMS therapy on motor cortex related to the painful limb, the VNS pain scores significantly decreased by 22% on average. The criterion of response was met in six of 11 patients (55%). In these responders, at one month after treatment, ESC value increased and returned to normal in the CRPS-affected limb, and overall, the increase in ESC correlated with the decrease in VNS after motor cortex rTMS therapy. At one month after treatment, there also was a covariance of both variables (ESC and VNS) with fMRI activation of the S1 region previously mentioned. The fMRI activation of other brain regions (middle frontal gyrus and temporo-parietal junction) showed correlation with ESC values before and after treatment. Finally, we found a positive correlation at one month after treatment (not at baseline) between VNS pain score and fMRI activation in the temporo-parietal junction contralateral to painful side.
This study first shows a functional pain-autonomic coupling in patients with CRPS, which could involve a specific S1 region. However, the modulation of sympathetic sudomotor activities expressed by ESC changes was rather correlated with functional changes in other brain regions. Finally, the pain relief observed at one month after rTMS treatment was associated with a reduced activation of the temporo-parietal junction on the side in which rTMS was performed. These findings open perspectives to define new targets or biomarkers for using rTMS to treat CRPS-associated pain.
The Clinicaltrials.gov registration number for the study is NCT02817880.
复杂区域疼痛综合征(CRPS)是一种涉及自主神经失调的慢性疼痛疾病。本研究报告了一项针对更大规模临床试验的辅助研究结果,该试验旨在通过神经调节治疗 CRPS。这项辅助研究基于功能磁共振成像(fMRI),评估了 CRPS 患者疼痛的神经相关性,涉及交感神经系统,以及重复经颅磁刺激(rTMS)对运动皮层的治疗后可能的缓解作用。
11 名单侧肢体 CRPS 患者(6 名女性,5 名男性,年龄 52.0±9.6 岁)在接受为期 5 个月的针对疼痛侧对侧运动皮层的 rTMS 治疗结束后 1 个月,通过电化学皮肤电导率(ESC)测量、每日视觉数字量表(VNS)疼痛评分和运动任务的 fMRI(手指运动和休息的交替)进行评估。使用 ESC 和 VNS 疼痛评分作为回归量对 fMRI 扫描进行体素分析,以得出其神经相关性。rTMS 治疗的反应标准定义为与基线相比,治疗后 1 个月 VNS 疼痛评分降低≥30%。
在基线时,与非受累肢体相比,受累肢体的 ESC 值降低。在 fMRI 研究中,VNS 与疼痛侧对侧初级体感皮层(S1)的脑激活存在协方差。在对与疼痛肢体相关的运动皮层进行 rTMS 治疗后,VNS 疼痛评分平均显著降低 22%。11 名患者中有 6 名(55%)符合反应标准。在这些应答者中,治疗后 1 个月,ESC 值在 CRPS 受累肢体中升高并恢复正常,并且总体上,运动皮层 rTMS 治疗后 ESC 的增加与 VNS 的降低相关。治疗后 1 个月,还观察到这两个变量(ESC 和 VNS)与之前提到的 S1 区域的 fMRI 激活之间存在协方差。中额叶回和颞顶联合区等其他脑区的 fMRI 激活与治疗前后的 ESC 值相关。最后,我们发现治疗后 1 个月(而非基线)VNS 疼痛评分与疼痛对侧颞顶联合区的 fMRI 激活之间存在正相关。
本研究首次在 CRPS 患者中显示出功能性疼痛-自主耦合,这可能涉及特定的 S1 区域。然而,ESC 变化所表达的交感神经排汗活动的调节与其他脑区的功能变化更为相关。最后,rTMS 治疗 1 个月后的疼痛缓解与在进行 rTMS 的侧颞顶联合区的激活减少相关。这些发现为使用 rTMS 治疗 CRPS 相关疼痛定义新的靶点或生物标志物开辟了前景。
该研究的 Clinicaltrials.gov 注册号为 NCT02817880。